Royal Bank of Canada
BLUE

Royal Bank of Canada’s bluebird bio BLUE Stock Holding History

Royal Bank of Canada’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,145
Closed -$5K – 7032
2025
Q1 		$5K Sell
1,145
-502
-30% -$3.02K ﹤0.01% 6340
2024
Q4 		$13K Buy
1,647
+382
+30% +$3.34K ﹤0.01% 6262
2024
Q3 		$13K Buy
1,265
+34
+3% +$565 ﹤0.01% 6246
2024
Q2 		$24K Buy
1,231
+682
+124% +$13.7K ﹤0.01% 5984
2024
Q1 		$13K Sell
549
-1,261
-70% -$32.3K ﹤0.01% 6088
2023
Q4 		$50K Buy
1,810
+505
+39% +$30.8K ﹤0.01% 5991
2023
Q3 		$80K Buy
1,305
+342
+36% +$24K ﹤0.01% 5523
2023
Q2 		$64K Buy
963
+65
+7% +$4.75K ﹤0.01% 5646
2023
Q1 		$57K Sell
898
-92
-9% -$10.5K ﹤0.01% 5547
2022
Q4 		$138K Buy
990
+585
+144% +$82.4K ﹤0.01% 5206
2022
Q3 		$52K Buy
405
+44
+12% +$4.98K ﹤0.01% 5715
2022
Q2 		$29K Buy
361
+20
+6% +$1.55K ﹤0.01% 5945
2022
Q1 		$33K Sell
341
-302
-47% -$39.9K ﹤0.01% 6328
2021
Q4 		$128K Sell
643
-198
-24% -$46.7K ﹤0.01% 5748
2021
Q3 		$208K Sell
841
-35,076
-98% -$10M ﹤0.01% 5135
2021
Q2 		$14.9M Sell
35,917
-245,387
-87% -$97.2M ﹤0.01% 1550
2021
Q1 		$110M Buy
281,304
+25,160
+10% +$12.4M 0.03% 432
2020
Q4 		$144M Buy
256,144
+33,557
+15% +$21.3M 0.04% 363
2020
Q3 		$156M Buy
222,587
+20,325
+10% +$15.9M 0.06% 288
2020
Q2 		$160M Buy
202,262
+114,776
+131% +$86.6M 0.06% 254
2020
Q1 		$52.1M Buy
87,486
+85,442
+4,180% +$83.3M 0.03% 492
2019
Q4 		$2.32M Sell
2,044
-190
-9% -$207K ﹤0.01% 2763
2019
Q3 		$2.66M Buy
2,234
+85
+4% +$130K ﹤0.01% 2529
2019
Q2 		$3.54M Buy
2,149
+230
+12% +$398K ﹤0.01% 2319
2019
Q1 		$3.91M Buy
1,919
+370
+24% +$652K ﹤0.01% 2185
2018
Q4 		$1.99M Sell
1,549
-3,629
-70% -$5.57M ﹤0.01% 2648
2018
Q3 		$9.79M Buy
5,178
+465
+10% +$961K ﹤0.01% 1631
2018
Q2 		$9.58M Buy
4,713
+1,932
+69% +$4.4M ﹤0.01% 1570
2018
Q1 		$6.15M Sell
2,781
-1,780
-39% -$4.53M ﹤0.01% 1860
2017
Q4 		$10.5M Buy
4,561
+3,820
+516% +$7.76M ﹤0.01% 1572
2017
Q3 		$1.32M Buy
741
+375
+102% +$524K ﹤0.01% 2997
2017
Q2 		$498K Sell
366
-227
-38% -$274K ﹤0.01% 3662
2017
Q1 		$698K Buy
593
+323
+120% +$329K ﹤0.01% 3373
2016
Q4 		$216K Sell
270
-304
-53% -$241K ﹤0.01% 4428
2016
Q3 		$503K Buy
574
+505
+732% +$366K ﹤0.01% 3705
2016
Q2 		$39K Buy
69
+9
+15% +$5.1K ﹤0.01% 5219
2016
Q1 		$34K Buy
60
+11
+22% +$6.76K ﹤0.01% 5281
2015
Q4 		$39K Buy
49
+38
+345% +$38K ﹤0.01% 5436
2015
Q3 		$12K Sell
11
-166
-94% -$303K ﹤0.01% 5801
2015
Q2 		$386K Buy
177
+80
+82% +$163K ﹤0.01% 3854
2015
Q1 		$151K Sell
97
-361
-79% -$476K ﹤0.01% 4393
2014
Q4 		$545K Buy
458
+341
+291% +$228K ﹤0.01% 3470
2014
Q3 		$54K Buy
117
+116
+11,600% +$53.5K ﹤0.01% 4908
2014
Q2 		$0 Hold
1
– – ﹤0.01% 5929
2014
Q1 		$0 Hold
1
– – ﹤0.01% 5902
2013
Q4 		$0 Sell
1
-1,256
-100% -$351K ﹤0.01% 5923
2013
Q3 		$438K Buy
+1,257
New +$467K ﹤0.01% 3482

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's BLUE Position: Q2 2025 in Review

Royal Bank of Canada sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 1,145 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $160M in Q2 2020. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Royal Bank of Canada reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1,145 bluebird bio shares in Q2 2025, an estimated $5K.
  • Royal Bank of Canada first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Royal Bank of Canada's bluebird bio position peaked at $160M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.